Mobocertinib (TAK-788) in EGFR exon 20 insertion+ metastatic NSCLC: Patient-reported outcomes from EXCLAIM extension cohort Meeting Abstract


Authors: García Campelo, M. R.; Zhou, C.; Ramalingam, S.; Lin, H.; Kim, T.; Riely, G.; Mekhail, T.; Nguyen, D.; Goodman, E.; Le, K.; Mehta, M.; Popat, S.; Janne, P.
Abstract Title: Mobocertinib (TAK-788) in EGFR exon 20 insertion+ metastatic NSCLC: Patient-reported outcomes from EXCLAIM extension cohort
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: health-related quality of life; non-small cell lung; cancer; exon20 insertion
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S960
End Page: S961
Language: English
ACCESSION: WOS:000709606500236
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.236
Notes: Meeting Abstract: FP09.02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely